News

Flagship Pioneering nabs $618 mln for sixth fund

Flagship Pioneering has raised $618 million for its sixth fund, according to an SEC filing. The Cambridge, Massachusetts-based venture firm invests in the health and sustainability sectors.

FLX Bio scores $60 mln Series C

South San Francisco-based FLX Bio Inc, a biopharmaceutical company focused on activating the immune system against cancer, has secured $60 million in Series C financing. The investors included GV, The Column Group, Kleiner Perkins, Topspin Partners and Celgene Corporation.

Temasek leads $80 mln round for Tessa Therapeutics

Singapore-based Tessa Therapeutics, a biopharmaceutical company focusing on T cell therapy for solid tumors, has closed $80 million in financing. Temasek led the round with participation from other investors that included EDBI, Karst Peak Capital, Heliconia and Heritas.

Fly Ventures rakes in $41 mln for maiden fund

Berlin-based Fly Ventures, a software-focused early-stage venture firm, has raised $41 million for its inaugural fund. The fund's limited partners include European Investment Fund, Korelya Capital and several family offices from Europe and the U.S.

OrbiMed, BlueRun, Sofinnova lead late-decade venture portfolio at CalSTRS

Lyft vs Uber: David vs. Goliath battle plays out in 2018

Irish biotech company Nuritas lands $20 mln Series A

Irish biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Year in Review: Venture-backed startups that went belly up in 2017

Inventus to raise third venture capital fund

Inventus Capital Partners has set out to raise a third venture capital fund, according to a filing with the SEC.

Luna DNA rakes in $2 mln seed

San Diego-based Luna DNA, a blockchain-powered genomic platform, has secured $2 million in seed funding. The investors included Illumina.